Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab and irinotecan in KRAS wild-type metastatic colorectal cancer
NCT00958386Phase 2Completed
- Sponsor
- Spanish Cooperative Group for Digestive Tumour Therapy
- Start
- Aug 2009
- Primary completion
- Jul 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of panitumumab in colorectal cancer (metastatic) (mCRC), sponsored by Spanish Cooperative Group for Digestive Tumour Therapy. Started Aug 2009; status: completed.
02
Drugs
panitumumab
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT00958386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00958386.